Synthesis of three strong UV-absorbing Naproxen-based chiral derivatizing agents and their application for enantioseparation of Baclofen by RP-HPLC

• Autorzy: Batra S. , Bhushan R.
• Języki publikacji: EN

Abstrakty

EN

A sensitive and stereoselective high-performance liquid chromatography (HPLC) method based on diastereomer formation was developed and fully validated for the simultaneous determination of the two enantiomers of Baclofen. (S)-Naproxen was used to prepare three chiral derivatizing reagents (CDRs) which were used for synthesizing diastereomers of Baclofen. The diastereomers so synthesized were separated on C18 column under reversed phase conditions using a binary mixture of acetonitrile and triethylammonium phosphate, with UV detection at 220 nm. The results obtained for enantioseparation of Baclofen using the three CDRs have been compiled and compared. The conditions for derivatization and chromatographic separation have been optimized. The method was validated for linearity, repeatability, limits of detection, and limit of quantification.

Słowa kluczowe

EN

Baclofen; Naproxen; indirect enantioseparation; reversed-phase HPLC; chiral derivatizing agents

• Wydawca: University of Silesia in Katowice ; Akademiai Kiado
• Czasopismo: Acta Chromatographica
• Rocznik: 2015
• Tom: Vol. 27, no. 2
• Strony: 267--280
• Opis fizyczny: Bibliogr. 24 poz., rys., tab.

Twórcy

autor

Batra S.

• Indian Institute of Technology Roorkee Department of Chemistry Roorkee 247667 India

autor

Bhushan R.

• Indian Institute of Technology Roorkee Department of Chemistry Roorkee 247667 India

Bibliografia

• [1] R. Bhushan and R. Dubey, J. Chromatogr. A, 1218, 3648 (2011)
• [2] R. Bhushan and H. Nagar, Biomed. Chromatogr., 27, 750 (2013)
• [3] R. Bhushan and S. Tanwar, J. Chromatogr. A, 1209, 174 (2008)
• [4] R. Bhushan and H. Nagar, Biomed. Chromatogr., DOI 10.1002/bmc.2903
• [5] J.S. Kroin, Clin. Pharmacokinet., 22, 319 (1992)
• [6] J. Sawynok and C. Dikson, Prog. Neuropsychopharmacol. Biol. Psychol., 8, 729 (1984)
• [7] Y. Hong and J.L. Henry, Eur. J. Pharmacol., 192, 55 (1991)
• [8] E.W. Wuis, E.W.J. Beneken Kolmer, L.E.C. Van Beijsterveldt, R.C.M. Burgers, T.B. Vree, and E. Van Der Kleyn, J. Chromatogr., 415, 419 (1987)
• [9] H. Spahn, D. Krauss, and E. Mutschler, Pharm., Res., 5, 107 (1988)
• [10] R. Bhushan and V. Kumar, Biomed. Chromatogr., 22 , 906 (2008)
• [11] R. Bhushan and S. Dixit, J. Chromatogr. A, 1217 , 6382 (2010)
• [12] R. Bhushan and S. Dixit, Biomed. Chromatogr., 26, 743 (2012)
• [13] A.A. Rat’ko and R.I. Stefan-van Staden, Farmaco, 59, 993 (2004)
• [14] R.I. Stefan-van Staden and A.A. Rat’ko, Talanta, 69, 1049 (2006)
• [15] R. Goda, N. Murayama, Y. Fujimaki, and K. Sudo, J. Chromatogr. B, 801, 257 (2004)
• [16] M.M. Hefnawy and H.Y. Aboul-Enein, Talanta, 61, 667 (2003)
• [17] Z. Zhu and L. Neirinck J. Chromatogr. B, 785, 277 (2003)
• [18] C. Vaccher, P. Berthelot and M. Debaert, J. Chromatogr. A, 715, 361 (1995)
• [19] C. Vaccher, P. Berthelot and M. Debaert, J. Chromatogr., 645, 95 (1993)
• [20] C. Vaccher, P. Berthelot, N. Flouquet, and M. Debaert, J. Chromatogr., 542, 502 (1991)
• [21] R.I. Stefan van Staden and A.A. Rat’ko, Talanta, 69, 1049 (2006)
• [22] M.P. Vaccher, E. Lipka, J.P. Bonte, C. Foulon, J.F. Goossens, and C. Vaccher, Electrophoresis, 26 , 2974 (2005)
• [23] K. Shimada, K. Mitamura, M. Morita, and K. Hirakata, J. Liq. Chromatogr., 16, 3311 (1993)
• [24] ICH Topic Q2B Validation of Analytical Procedures. In: Proceedings of the International Conference on Harmonization of Technical Requirement for Registration of Pharmaceuticals for Human Use, 1996